A 2-year placebo-controlled study of orlistat in the treatment of obesity.

被引：0
|
作者：
Lucas, C
机构：
来源：
DIABETES | 1997年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [41] Effects of a novel weight-loss combination product containing orlistat and acarbose on obesity: A randomized, placebo-controlled trial
    Holmback, Ulf
    Gruden, Stefan
    Litorp, Helena
    Willhems, Daniel
    Kuusk, Sandra
    Alderborn, Goran
    Soderhall, Arvid
    Forslund, Anders
    OBESITY, 2022, 30 (11) : 2222 - 2232
  • [42] Soy protein supplementation in men following radical prostatectomy: a 2-year randomized, placebo-controlled clinical trial
    Bosland, Maarten C.
    Enk, Erika
    Schmoll, Joanne
    Schlicht, Michael J.
    Randolph, Carla
    Deaton, Ryan J.
    Xie, Hui
    Zeleniuch-Jacquotte, Anne
    Kato, Ikuko
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2021, 113 (04): : 821 - 831
  • [43] Randomized placebo-controlled trial of orlistat for the treatment of patients with non alcoholic fatty liver disease (NAFLD)
    Zelber-Sagi, S
    Kessler, A
    Brazowsky, E
    Webb, M
    Lurie, Y
    Santo, M
    Leshno, M
    Blendis, LM
    Halpern, Z
    Oren, R
    HEPATOLOGY, 2004, 40 (04) : 237A - 237A
  • [44] A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
    Zelber-Sagi, Shira
    Kessler, Ada
    Brazowsky, Eli
    Webb, Muriel
    Lurie, Yoav
    Santo, Moshe
    Leshno, Moshe
    Blendis, Laurence
    Halpern, Zamir
    Oren, Ran
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (05) : 639 - 644
  • [45] Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomized, placebo-controlled study in healthy early postmenopausal women
    Vogelvang, TE
    Leurs, JR
    van der Mooren, MJ
    Mijatovic, V
    Hendriks, DF
    Neele, SJM
    Netelenbos, JC
    Kenemans, P
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (01): : 110 - 115
  • [46] Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: A 2-year randomized, placebo-controlled, comparative study
    Post, MS
    van der Mooren, MJ
    van Baal, WM
    Neele, SJM
    Netelenbos, JC
    Kenemans, P
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (03) : 557 - 562
  • [47] A randomized, placebo-controlled trial of intravitreal triamcinolone acetonide for diabetic macular edema that persists or recurs after laser treatment - 2-year results
    Gillies, MC
    Zhu, M
    Simpson, JM
    Sutter, FKP
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [48] CONTINUOUS COMBINED AND SEQUENTIAL ESTRADIOL AND NORETHINDRONE ACETATE TREATMENT OF POSTMENOPAUSAL WOMEN - EFFECT ON PLASMA-LIPOPROTEINS IN A 2-YEAR PLACEBO-CONTROLLED TRIAL
    MUNKJENSEN, N
    ULRICH, LG
    OBEL, EB
    NIELSEN, SP
    EDWARDS, D
    MEINERTZ, H
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (01) : 132 - 138
  • [49] Early treatment of migraine with rizatriptan: A placebo-controlled study
    Mathew, NT
    Kailasam, J
    Meadors, L
    HEADACHE, 2004, 44 (07): : 669 - 673
  • [50] PRAZOSIN IN THE TREATMENT OF PROSTATIC OBSTRUCTION - A PLACEBO-CONTROLLED STUDY
    KIRBY, RS
    COPPINGER, SWC
    CORCORAN, MO
    CHAPPLE, CR
    FLANNIGAN, M
    MILROY, EJG
    BRITISH JOURNAL OF UROLOGY, 1987, 60 (02): : 136 - 142
12345